Inventor

SIEGER PETER

DE40 patents

⚠️ This page may combine multiple inventors who share the name “SIEGER PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SIEGER PETER

BOEHRINGER INGELHEIM INT

Specific salt, anhydrous and crystalline form of a dihydropteridione derivative

3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as a medicament

Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament

Enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments

Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments

Polymorphs

Polymorphs

Polymorphs

Hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament

Polymorphs

Solid forms of a GlyT1 inhibitor

Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments

Enantiomerically pure beta agonists, manufacturing and use thereof

Enantiomeric pure β agonists, manufacturing and use as a medicament thereof

Polymorphs

Enantiomeric pure beta agonists, manufacturing and use as a medicaments thereof

(R) 2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1 (pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition

BOEHRINGER INGELHEIM PHARMA

Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions

Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions

Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition

3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition

Meloxicam for oral administration

Benzoylguanidine salt and hydrates thereof

(R)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition

Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions

LINZ GUENTER

Specific salt, anhydrous and crystalline form of a dihydropteridione derivative

Methods of using hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide

Crystalline form of the free base N-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7r)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxy-benzamide

Specific salt, anhydrous and crystalline form of a dihydropteridione derivative

SIEGER PETER

Salt forms of a xanthine compound

Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine

Polymorphs

PFRENGLE WALDEMAR

8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals

8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals

9-[4-(3-chloro-2-fluoro-phenylamino-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5]undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof

SOYKA RAINER

Process for preparing amino crotonyl compounds

BOEHRINGER INGELHEIN INTERNAT GMBH

Crystalline anhydrate with anticholinergic efficacy

PFRENGLE WALDERMAR

9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5] undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof

OSTERMEIER MARKUS

Fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one, its use as a medicament and the preparation thereof

BANHOLZER ROLF

Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof